[HTML][HTML] Molecular immune pathogenesis and diagnosis of COVID-19
X Li, M Geng, Y Peng, L Meng, S Lu - Journal of pharmaceutical analysis, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of …
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of …
[HTML][HTML] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li, J Wu… - Computational and …, 2022 - Elsevier
Abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …
Host immune response and immunobiology of human SARS-CoV-2 infection
S Kumar, R Nyodu, VK Maurya, SK Saxena - Coronavirus Disease 2019 …, 2020 - Springer
One of the most serious viral outbreaks of the decade, infecting humans, originated from the
city of Wuhan, China, by the end of December 2019, has left the world shaken up. It is the …
city of Wuhan, China, by the end of December 2019, has left the world shaken up. It is the …
Monocytes and macrophages in COVID-19: Friends and foes
S Meidaninikjeh, N Sabouni, HZ Marzouni, S Bengar… - Life sciences, 2021 - Elsevier
The COVID-19 is a novel infectious disease caused by SARS-CoV-2 and is known as a
pandemic emergency that has led to a high rate of mortality throughout the world. Evidence …
pandemic emergency that has led to a high rate of mortality throughout the world. Evidence …
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
Such testing and trying time probably never seen before in the human history. The novel
coronavirus disease abbreviated as COVID-19 is the ongoing health crisis which entered …
coronavirus disease abbreviated as COVID-19 is the ongoing health crisis which entered …
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential …
A Jafarzadeh, P Chauhan, B Saha, S Jafarzadeh… - Life sciences, 2020 - Elsevier
Abstract The COVID-19-, SARS-and MERS-related coronaviruses share many genomic and
structural similarities. However, the SARS-CoV-2 is less pathogenic than SARS-CoV and …
structural similarities. However, the SARS-CoV-2 is less pathogenic than SARS-CoV and …
[HTML][HTML] Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach
L Lu, LP Liu, R Gui, H Dong, YR Su, XH Zhou… - Frontiers in …, 2022 - frontiersin.org
Corona Virus Disease 2019 (COVID-19), an acute respiratory infectious disease caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread rapidly …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread rapidly …
[HTML][HTML] Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning
BK Patterson, J Guevara-Coto, R Yogendra… - Frontiers in …, 2021 - frontiersin.org
Expression of CCR5 and its cognate ligands have been implicated in COVID-19
pathogenesis, consequently therapeutics directed against CCR5 are being investigated …
pathogenesis, consequently therapeutics directed against CCR5 are being investigated …
Cytokine storm in COVID‐19 patients, its impact on organs and potential treatment by QTY code‐designed detergent‐free chemokine receptors
MI Mustafa, AH Abdelmoneim… - Mediators of …, 2020 - Wiley Online Library
The novel coronavirus is not only causing respiratory problems, but it may also damage the
heart, kidneys, liver, and other organs; in Wuhan, 14 to 30% of COVID‐19 patients have lost …
heart, kidneys, liver, and other organs; in Wuhan, 14 to 30% of COVID‐19 patients have lost …
[HTML][HTML] Cellular immune response to COVID-19 and potential immune modulators
X Zhou, Q Ye - Frontiers in immunology, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as …